Vanessa Baier

425 total citations
27 papers, 228 citations indexed

About

Vanessa Baier is a scholar working on Clinical Psychology, Pharmacology and General Health Professions. According to data from OpenAlex, Vanessa Baier has authored 27 papers receiving a total of 228 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Clinical Psychology, 6 papers in Pharmacology and 5 papers in General Health Professions. Recurrent topics in Vanessa Baier's work include Child and Adolescent Psychosocial and Emotional Development (10 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Schizophrenia research and treatment (4 papers). Vanessa Baier is often cited by papers focused on Child and Adolescent Psychosocial and Emotional Development (10 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Schizophrenia research and treatment (4 papers). Vanessa Baier collaborates with scholars based in Germany, Switzerland and United States. Vanessa Baier's co-authors include Lars Kuepfer, Lars M. Blank, Christoph Thiel, Laurent Holzer, Sébastien Urben, Hélène E. Aschmann, Stephan Schaller, Colin G. Scanes, Thomas G. Preuß and Jérôme Favrod and has published in prestigious journals such as The Science of The Total Environment, Antimicrobial Agents and Chemotherapy and Environment International.

In The Last Decade

Vanessa Baier

23 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vanessa Baier Germany 10 52 40 37 36 30 27 228
Valérie Lameyre France 10 44 0.8× 25 0.6× 54 1.5× 33 0.9× 11 0.4× 15 388
Rachel Clarke United States 10 46 0.9× 42 1.1× 18 0.5× 50 1.4× 44 1.5× 39 399
Alexander Croft United Kingdom 11 20 0.4× 24 0.6× 20 0.5× 15 0.4× 11 0.4× 23 311
Dawit A. Ejigu Ethiopia 8 45 0.9× 16 0.4× 11 0.3× 30 0.8× 6 0.2× 10 209
Chieko Sugishita Japan 12 36 0.7× 19 0.5× 20 0.5× 84 2.3× 11 0.4× 30 493
Anu Bhardwaj India 11 32 0.6× 43 1.1× 16 0.4× 89 2.5× 8 0.3× 41 406
Rachel Jackson United Kingdom 9 62 1.2× 82 2.0× 7 0.2× 44 1.2× 4 0.1× 15 367
Andrew Lau Australia 8 77 1.5× 17 0.4× 54 1.5× 77 2.1× 5 0.2× 13 449
Ricardo Navarro García Chile 8 100 1.9× 30 0.8× 8 0.2× 7 0.2× 12 0.4× 33 305
Yixing Ren China 9 72 1.4× 103 2.6× 7 0.2× 22 0.6× 28 0.9× 24 325

Countries citing papers authored by Vanessa Baier

Since Specialization
Citations

This map shows the geographic impact of Vanessa Baier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Baier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Baier more than expected).

Fields of papers citing papers by Vanessa Baier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Baier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Baier. The network helps show where Vanessa Baier may publish in the future.

Co-authorship network of co-authors of Vanessa Baier

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Baier. A scholar is included among the top collaborators of Vanessa Baier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Baier. Vanessa Baier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schaller, Stephan, et al.. (2024). Evaluation of BCRP-Related DDIs Between Methotrexate and Cyclosporin A Using Physiologically Based Pharmacokinetic Modelling. Drugs in R&D. 25(1). 1–17. 1 indexed citations
2.
Bauer, Barbara, et al.. (2023). Reproductive toxicity in birds predicted by physiologically-based kinetics and bioenergetics modelling. The Science of The Total Environment. 912. 169096–169096. 5 indexed citations
3.
Schneider, Carolin V., Kai Markus Schneider, Vanessa Baier, et al.. (2022). Early prediction of decompensation (EPOD) score: Non‐invasive determination of cirrhosis decompensation risk. Liver International. 42(3). 640–650. 12 indexed citations
4.
Scanes, Colin G., et al.. (2022). Quantitative Morphometric, Physiological, and Metabolic Characteristics of Chickens and Mallards for Physiologically Based Kinetic Model Development. Frontiers in Physiology. 13. 858283–858283. 5 indexed citations
5.
Scanes, Colin G., et al.. (2022). Quantitative Comparison of Avian and Mammalian Physiologies for Parameterization of Physiologically Based Kinetic Models. Frontiers in Physiology. 13. 858386–858386. 8 indexed citations
6.
Baier, Vanessa, Alicia Paini, Stephan Schaller, et al.. (2022). A generic avian physiologically-based kinetic (PBK) model and its application in three bird species. Environment International. 169. 107547–107547. 18 indexed citations
7.
Baier, Vanessa, Alicia Paini, Stephan Schaller, et al.. (2022). A Generic Avian Physiologically-Based Kinetic (Pbk) Model and its Application in Three Bird Species. SSRN Electronic Journal. 2 indexed citations
8.
Baier, Vanessa, Olivia Clayton, Ramona Nudischer, et al.. (2021). A Model‐Based Workflow to Benchmark the Clinical Cholestasis Risk of Drugs. Clinical Pharmacology & Therapeutics. 110(5). 1293–1301. 2 indexed citations
9.
Baier, Vanessa, Christoph Thiel, José V. Castell, et al.. (2019). A Physiology-Based Model of Human Bile Acid Metabolism for Predicting Bile Acid Tissue Levels After Drug Administration in Healthy Subjects and BRIC Type 2 Patients. Frontiers in Physiology. 10. 1192–1192. 10 indexed citations
10.
Thiel, Christoph, et al.. (2018). Integration of genome-scale metabolic networks into whole-body PBPK models shows phenotype-specific cases of drug-induced metabolic perturbation. npj Systems Biology and Applications. 4(1). 10–10. 29 indexed citations
11.
Thiel, Christoph, et al.. (2018). Using quantitative systems pharmacology to evaluate the drug efficacy of COX-2 and 5-LOX inhibitors in therapeutic situations. npj Systems Biology and Applications. 4(1). 28–28. 15 indexed citations
12.
Baier, Vanessa, et al.. (2018). Clinical significance of assertive community treatment among adolescents. Social Psychiatry and Psychiatric Epidemiology. 54(4). 445–453. 11 indexed citations
13.
Thiel, Christoph, Hélène E. Aschmann, Vanessa Baier, et al.. (2017). A Comparative Analysis of Drug-Induced Hepatotoxicity in Clinically Relevant Situations. PLoS Computational Biology. 13(2). e1005280–e1005280. 9 indexed citations
14.
15.
Urben, Sébastien, et al.. (2016). Timing of Clinical Improvement in Assertive Community Treatment for Adolescents: A Pilot Naturalistic Observational Study. Archives of Psychiatric Nursing. 30(5). 645–646. 3 indexed citations
16.
Thiel, Christoph, et al.. (2016). A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy. Antimicrobial Agents and Chemotherapy. 60(10). 6134–6145. 35 indexed citations
17.
Urben, Sébastien, et al.. (2015). Clinical Utility of the 2 New Scales of the Health of the Nation Outcome Scales for Children and Adolescents (HoNOSCA). Journal of Psychiatric Practice. 21(3). 232–240. 7 indexed citations
18.
Urben, Sébastien, et al.. (2015). Predictors and Moderators of Clinical Outcomes in Adolescents with Severe Mental Disorders After an Assertive Community Treatment. Child Psychiatry & Human Development. 46(6). 997–1005. 3 indexed citations
19.
20.
Bonsack, Charles, et al.. (2008). Equipes de psychiatrie mobiles pour les trois âges de la vie: l'expérience lausannoise [Psychiatric mobile teams for the three ages of live: the Lausanne experience]. Revue Médicale Suisse. 4(171).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valérie Lameyre Breakdown of academic impact, for papers by Rachel Clarke Breakdown of academic impact, for papers by Alexander Croft Breakdown of academic impact, for papers by Dawit A. Ejigu Breakdown of academic impact, for papers by Chieko Sugishita Breakdown of academic impact, for papers by Anu Bhardwaj Breakdown of academic impact, for papers by Rachel Jackson Breakdown of academic impact, for papers by Andrew Lau Breakdown of academic impact, for papers by Ricardo Navarro García Breakdown of academic impact, for papers by Yixing Ren
Rankless by CCL
2026